Qilian International Holding Group Company Overview
About Qilian International Holding Group
Qilian International Holding Group (NASDAQ:QLI) is a diversified company focused on the development, manufacture, and sales of pharmaceutical and chemical products. With operations based in China, Qilian International extends its expertise across areas such as licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD), and heparin products, aiming to cater to a broad range of healthcare needs. The company's projects span from the extraction and processing of raw materials to the development of innovative healthcare solutions, reflecting a commitment to high-quality products and the well-being of its customers. Qilian International's objectives are anchored in expanding its market presence, pioneering research and development in the pharmaceutical and chemical sectors, and driving sustainable growth while maintaining environmental stewardship.
Snapshot
Operations
Produtos e/ou serviços de Qilian International Holding Group
- Licensing of Traditional Chinese Medicine derivatives for various health conditions, enhancing accessibility and effectiveness globally.
- Development of Jitai Tablets, addressing opioid withdrawal symptoms and assisting in addiction recovery.
- Manufacture and supply of high-quality heparin products, critical for blood anticoagulation treatments worldwide.
- Innovative formulations of Osteoarthritis treatments, providing pain relief and improved joint function.
- Production of silymarin, a natural liver protection compound, supporting liver health and detoxification.
- Advanced API (Active Pharmaceutical Ingredients) processing capabilities, ensuring purity and efficacy for pharmaceutical industry partners.
equipe executiva do Qilian International Holding Group
- Mr. Zhanchang XinChairman of the Board, President, COO & Chief Scientific Officer
- Mr. Chen XinChief Executive Officer
- Ms. Yaxuan ZhaiChief Financial Officer